Free Trial

Best Stocks Under $5 Right Now

It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $5.00 (5 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts.

atai Life Sciences stock logo

1. atai Life Sciences NASDAQ:ATAI

$2.63 -0.12 (-4.36%)
Closing price 07/8/2025 04:00 PM Eastern
Extended Trading
$2.66 +0.04 (+1.33%)
As of 07/8/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Atai Life Sciences N.V., a clinical-stage biopharmaceutical company, develops and invests in various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. More about atai Life Sciences

Market Capitalization
$550.93 million
P/E Ratio
-2.89
Consensus Rating
Strong Buy
Consensus Price Target
$9.00 (+242.2% Upside)
Volume
4.34 million shares
Average Volume
2.05 million shares
TuHURA Biosciences stock logo

2. TuHURA Biosciences NASDAQ:HURA

$2.48 +0.08 (+3.33%)
Closing price 07/8/2025 04:00 PM Eastern
Extended Trading
$2.48 0.00 (0.00%)
As of 07/8/2025 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TuHURA Biosciences, Inc (NASDAQ: HURA) is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. More about TuHURA Biosciences

Market Capitalization
$104.83 million
Consensus Rating
Buy
Consensus Price Target
$12.67 (+410.8% Upside)
Volume
216,755 shares
Average Volume
264,044 shares
Today's Range
$2.38
$2.55
zSpace stock logo

3. zSpace NASDAQ:ZSPC

$3.09 +0.06 (+1.98%)
As of 07/8/2025 04:00 PM Eastern

zSpace Technologies, Inc is a provider of commercial augmented reality and virtual reality technology principally in the education market. More about zSpace

Market Capitalization
$69.33 million
Consensus Rating
Buy
Consensus Price Target
$15.00 (+385.4% Upside)
Volume
109,677 shares
Average Volume
41,789 shares
Today's Range
$2.90
$3.12
Telecom Italia stock logo

4. Telecom Italia OTCMKTS:TIIAY

$4.83 +0.02 (+0.31%)
As of 07/8/2025 03:32 PM Eastern

Telecom Italia S.p.A., together with its subsidiaries, engages in the provision of fixed and mobile telecommunications services in Italy and internationally. More about Telecom Italia

Consensus Rating
Buy
Volume
10,424 shares
Average Volume
17,062 shares
Today's Range
$4.80
$4.84
50-Day Range
$3.91
$4.90
52-Week Range
$2.19
$4.90
OS Therapies stock logo

5. OS Therapies NYSE:OSTX

$1.62 -0.11 (-6.36%)
Closing price 07/8/2025 04:00 PM Eastern
Extended Trading
$1.64 +0.02 (+1.54%)
As of 07/8/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. More about OS Therapies

Market Capitalization
$45.52 million
P/E Ratio
-1.88
Consensus Rating
Buy
Consensus Price Target
$18.00 (+1,011.1% Upside)
Volume
492,116 shares
Average Volume
492,354 shares
Western Copper & Gold stock logo

6. Western Copper & Gold NYSE:WRN

$1.23 0.00 (0.00%)
As of 07/8/2025 04:00 PM Eastern

Western Copper & Gold Corp. operates as an exploration stage company, which engages in the acquisition, exploration, and future development of mineral resource properties. More about Western Copper & Gold

Market Capitalization
$246.28 million
P/E Ratio
-61.50
Consensus Rating
Buy
Consensus Price Target
$4.00 (+225.2% Upside)
Volume
845,570 shares
Average Volume
372,237 shares
OnKure Therapeutics stock logo

7. OnKure Therapeutics NASDAQ:OKUR

$2.46 +0.07 (+2.93%)
Closing price 07/8/2025 04:00 PM Eastern
Extended Trading
$2.46 +0.00 (+0.20%)
As of 07/8/2025 06:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OnKure Therapeutics, Inc engages in discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. More about OnKure Therapeutics

Market Capitalization
$32.29 million
P/E Ratio
-0.47
Consensus Rating
Buy
Consensus Price Target
$32.33 (+1,214.4% Upside)
Volume
81,675 shares
Average Volume
107,938 shares
Reviva Pharmaceuticals stock logo

8. Reviva Pharmaceuticals NASDAQ:RVPH

$0.38 +0.01 (+2.64%)
Closing price 07/8/2025 04:00 PM Eastern
Extended Trading
$0.38 +0.00 (+1.17%)
As of 07/8/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Reviva Pharmaceuticals Holdings, Inc, a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. More about Reviva Pharmaceuticals

Market Capitalization
$17.61 million
P/E Ratio
-0.48
Consensus Rating
Buy
Consensus Price Target
$9.00 (+2,289.8% Upside)
Volume
2.83 million shares
Average Volume
1.36 million shares
GeoVax Labs stock logo

9. GeoVax Labs NASDAQ:GOVX

$0.65 +0.15 (+29.03%)
As of 07/8/2025 04:00 PM Eastern

GeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. More about GeoVax Labs

Market Capitalization
$8 million
P/E Ratio
-0.18
Consensus Rating
Buy
Consensus Price Target
$11.10 (+1,613.0% Upside)
Volume
5.97 million shares
Average Volume
2.58 million shares
Quince Therapeutics stock logo

10. Quince Therapeutics NASDAQ:QNCX

$1.61 -0.02 (-1.23%)
Closing price 07/8/2025 04:00 PM Eastern
Extended Trading
$1.60 -0.01 (-0.31%)
As of 07/8/2025 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Quince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. More about Quince Therapeutics

Market Capitalization
$74.11 million
P/E Ratio
-1.16
Consensus Rating
Buy
Consensus Price Target
$8.00 (+396.9% Upside)
Volume
212,332 shares
Average Volume
309,265 shares
Denison Mine stock logo

11. Denison Mine NYSEAMERICAN:DNN

$1.73 -0.08 (-4.42%)
Closing price 07/8/2025 04:10 PM Eastern
Extended Trading
$1.74 +0.01 (+0.29%)
As of 07/8/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Denison Mines Corp. engages in the acquisition, exploration, and development of uranium bearing properties in Canada. Its flagship project is the Wheeler River uranium project covering an area of approximately 300,000 hectares located in the Athabasca Basin region in northern Saskatchewan. More about Denison Mine

Market Capitalization
$1.62 billion
P/E Ratio
-21.63
Consensus Rating
Buy
Consensus Price Target
$3.00 (+73.4% Upside)
Volume
103.50 million shares
Average Volume
50.79 million shares
Endeavour Silver stock logo

12. Endeavour Silver NYSE:EXK

$4.85 -0.39 (-7.44%)
Closing price 07/8/2025 03:59 PM Eastern
Extended Trading
$4.96 +0.12 (+2.37%)
As of 07/8/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Endeavour Silver Corp., a silver mining company, engages in the acquisition, exploration, development, extraction, processing, refining, and reclamation of mineral properties in Chile and the United States. More about Endeavour Silver

Market Capitalization
$1.52 billion
P/E Ratio
-18.65
Consensus Rating
Buy
Consensus Price Target
$6.83 (+40.9% Upside)
Volume
12.96 million shares
Average Volume
9.07 million shares
MannKind stock logo

13. MannKind NASDAQ:MNKD

$3.62 +0.08 (+2.26%)
Closing price 07/8/2025 04:00 PM Eastern
Extended Trading
$3.62 +0.00 (+0.11%)
As of 07/8/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. More about MannKind

Market Capitalization
$1.08 billion
P/E Ratio
36.20
Consensus Rating
Buy
Consensus Price Target
$10.33 (+185.5% Upside)
Volume
2.54 million shares
Average Volume
2.43 million shares
Full House Resorts stock logo

14. Full House Resorts NASDAQ:FLL

$4.19 -0.11 (-2.56%)
As of 07/8/2025 04:00 PM Eastern

Full House Resorts, Inc owns, leases, operates, develops, manages, and invests in casinos, and related hospitality and entertainment facilities in the United States. More about Full House Resorts

Market Capitalization
$154.70 million
P/E Ratio
-3.77
Consensus Rating
Buy
Consensus Price Target
$5.67 (+35.2% Upside)
Volume
186,116 shares
Average Volume
175,147 shares
Hochschild Mining stock logo

15. Hochschild Mining OTCMKTS:HCHDF

$3.61 -0.16 (-4.19%)
As of 07/8/2025 11:40 AM Eastern

Hochschild Mining plc, a precious metals company, engages in the exploration, mining, processing, and sale of gold and silver in the Americas. More about Hochschild Mining

Market Capitalization
$1.94 billion
Consensus Rating
Buy
Volume
17,981 shares
Average Volume
25,931 shares
Today's Range
$3.59
$3.83
50-Day Range
$3.20
$4.21
Rezolve AI stock logo

16. Rezolve AI NASDAQ:RZLV

$2.61 -0.04 (-1.51%)
Closing price 07/8/2025 04:00 PM Eastern
Extended Trading
$2.61 0.00 (-0.15%)
As of 07/8/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Rezolve AI Plc operates in the mobile commerce industry with its cutting-edge engagement platform powered by artificial intelligence and machine learning. More about Rezolve AI

Market Capitalization
$551.89 million
Consensus Rating
Buy
Consensus Price Target
$6.00 (+129.9% Upside)
Volume
6.78 million shares
Average Volume
5.63 million shares
Today's Range
$2.58
$2.75
Immunic stock logo

17. Immunic NASDAQ:IMUX

$0.83 +0.06 (+8.39%)
Closing price 07/8/2025 04:00 PM Eastern
Extended Trading
$0.82 -0.01 (-0.75%)
As of 07/8/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Immunic, Inc, a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. More about Immunic

Market Capitalization
$73.30 million
P/E Ratio
-0.67
Consensus Rating
Buy
Consensus Price Target
$11.60 (+1,298.9% Upside)
Volume
1.13 million shares
Average Volume
977,632 shares
Alumis stock logo

18. Alumis NASDAQ:ALMS

$3.48 +0.17 (+5.14%)
Closing price 07/8/2025 04:00 PM Eastern
Extended Trading
$3.48 0.00 (-0.14%)
As of 07/8/2025 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Our mission is to significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. More about Alumis

Market Capitalization
$180.08 million
Consensus Rating
Buy
Consensus Price Target
$22.86 (+556.8% Upside)
Volume
490,303 shares
Average Volume
431,264 shares
Today's Range
$3.33
$3.55
Genelux stock logo

19. Genelux NASDAQ:GNLX

$3.48 +0.58 (+20.00%)
Closing price 07/8/2025 04:00 PM Eastern
Extended Trading
$3.46 -0.02 (-0.72%)
As of 07/8/2025 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. More about Genelux

Market Capitalization
$109.43 million
P/E Ratio
-3.95
Consensus Rating
Buy
Consensus Price Target
$17.75 (+410.1% Upside)
Volume
408,846 shares
Average Volume
175,435 shares
NRx Pharmaceuticals stock logo

20. NRx Pharmaceuticals NASDAQ:NRXP

$3.38 +0.01 (+0.30%)
Closing price 07/8/2025 04:00 PM Eastern
Extended Trading
$3.38 0.00 (0.00%)
As of 07/8/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NRx Pharmaceuticals, Inc, a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders, including suicidal depression, post-traumatic stress disorder, and chronic pain. More about NRx Pharmaceuticals

Market Capitalization
$58.26 million
P/E Ratio
-1.68
Consensus Rating
Buy
Consensus Price Target
$28.50 (+743.2% Upside)
Volume
163,664 shares
Average Volume
420,556 shares
Electrovaya stock logo

21. Electrovaya NASDAQ:ELVA

$3.43 +0.25 (+7.86%)
Closing price 07/8/2025 04:00 PM Eastern
Extended Trading
$3.58 +0.15 (+4.23%)
As of 07/8/2025 07:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Electrovaya Inc engages in the design, development, manufacture, and sale of lithium-ion batteries, battery management systems, and battery-related products for energy storage, clean electric transportation, and other specialized applications in North America. More about Electrovaya

Market Capitalization
$127.54 million
Consensus Rating
Buy
Consensus Price Target
$6.10 (+77.8% Upside)
Volume
93,584 shares
Average Volume
61,170 shares
Today's Range
$3.21
$3.44
Ceragon Networks stock logo

22. Ceragon Networks NASDAQ:CRNT

$2.58 +0.03 (+1.18%)
Closing price 07/8/2025 04:00 PM Eastern
Extended Trading
$2.62 +0.04 (+1.74%)
As of 07/8/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ceragon Networks Ltd., together with its subsidiaries, provides wireless transport solutions for cellular operators and other wireless service providers in North America, Europe, Africa, the Asia Pacific, the Middle East, India, and Latin America. More about Ceragon Networks

Market Capitalization
$226.77 million
P/E Ratio
9.92
Consensus Rating
Buy
Consensus Price Target
$6.00 (+132.6% Upside)
Volume
609,101 shares
Average Volume
1.12 million shares
Orchestra BioMed stock logo

23. Orchestra BioMed NASDAQ:OBIO

$2.93 +0.04 (+1.38%)
Closing price 07/8/2025 04:00 PM Eastern
Extended Trading
$2.95 +0.02 (+0.68%)
As of 07/8/2025 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Orchestra BioMed Holdings, Inc operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension (HTN); and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. More about Orchestra BioMed

Market Capitalization
$110.72 million
P/E Ratio
-1.65
Consensus Rating
Buy
Consensus Price Target
$14.20 (+384.6% Upside)
Volume
189,721 shares
Average Volume
187,909 shares
Mereo BioPharma Group stock logo

24. Mereo BioPharma Group NASDAQ:MREO

$2.83 -0.09 (-3.08%)
Closing price 07/8/2025 04:00 PM Eastern
Extended Trading
$2.86 +0.02 (+0.88%)
As of 07/8/2025 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. More about Mereo BioPharma Group

Market Capitalization
$464.28 million
P/E Ratio
-40.43
Consensus Rating
Buy
Consensus Price Target
$7.60 (+168.6% Upside)
Volume
2.06 million shares
Average Volume
1.11 million shares
ImmunityBio stock logo

25. ImmunityBio NASDAQ:IBRX

$2.71 -0.01 (-0.37%)
Closing price 07/8/2025 04:00 PM Eastern
Extended Trading
$2.71 0.00 (0.00%)
As of 07/8/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ImmunityBio, Inc, a clinical-stage biotechnology company, engages in developing therapies and vaccines that bolster the natural immune system to defeat cancers and infectious diseases. More about ImmunityBio

Market Capitalization
$2.40 billion
P/E Ratio
-4.67
Consensus Rating
Buy
Consensus Price Target
$12.25 (+352.0% Upside)
Volume
6.01 million shares
Average Volume
6.21 million shares